Phase 1 study of KVD818 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 14 Sep 2017
At a glance
- Drugs KVD 818 (Primary)
- Indications Hereditary angioedema
- Focus Adverse reactions; First in man
- 14 Sep 2017 According to a KalVista Pharmaceuticals media released, the company is about to complete this trial and plans to evaluate the final data.
- 01 Sep 2016 New trial record
- 11 Aug 2016 According to KalVista media release, company announced the dosing of first patient in this trial.